Esta web utiliza cookies propias y de terceros para mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí.
The cookies are associated only with an anonymous user, not allowing to access to personal data information nor to information in the hardware.
The User may disable, at any time, through it navigation settings, the personalization system of the website. The user may, at any time, modify the navigation setting to delete cookies automatically without affecting the ability to continue using most of the services offered on the Website.
The sole usage of the Website, taking into account the adequate parameters of the navigator configured for the usage of cookies, implies the acceptance of them. All before mentioned, will allow to the Website to install cookies when it is strictly necessary for the usage of the Website.
This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.
PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° , resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases